Helle Broholm

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen et al. · Neuro-Oncology · 2010 · 227 citations · Full text

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

Jiřina Bártková, Petra Hamerlik, M.-T. Stockhausen et al. · Oncogene · 2010 · 173 citations

Reductive Stress, Neuro-oncology, Genome Instability +13

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

Signe Regner Michaelsen, Ib Jarle Christensen, Kirsten Grunnet et al. · BMC Cancer · 2013 · 86 citations · Full text

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance

Signe Regner Michaelsen, Mikkel Staberg, Henriette Pedersen et al. · Neuro-Oncology · 2018 · 86 citations · Full text

Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non‐tumour brain tissue

Gitte Petersen, Birthe Moesgaard, Patricia C. Schmid et al. · Journal of Neurochemistry · 2005 · 83 citations · Full text